BASF Approaches Evonik in Bid to Build Chemicals Giant
By @sharedot · · 6 pages
- Business
- Mergers And Acquisitions
- Chemicals
BASF has made a non-binding takeover approach to Evonik, creating a potential European chemicals giant as the sector faces Chinese competition.
What happened: exploratory talks confirmed
BASF, among the world's largest chemicals makers, has approached smaller German peer Evonik about a possible takeover that would strengthen its portfolio as European companies face tough competition from China.
Evonik confirmed it had "received a non-binding approach from BASF regarding a voluntary public takeover offer for all shares of the company," and the RAG Foundation, which holds 43% of Evonik, said it had also been contacted.
BASF said it continuously evaluates "the strategic option of acquisitions that strengthen its core businesses, deliver a strong strategic fit, drive profitable growth and create value" and was in exploratory talks, stressing the outcome was "open at this stage."
Evonik, for its part, said no discussion was yet underway. According to Reuters reporting carried by both outlets, the Financial Times earlier reported BASF had approached Evonik and its biggest shareholder.
Why it is surprising: markets move fast
The market reaction was immediate and sharply divided. Evonik shares continued a recent rally that traders said was partly driven by takeover speculation, closing 7.2% higher on Friday, while BASF shares fell 3.6%.
The size gap is striking: BASF has a market capitalisation of €45.8 billion ($52.2 billion), while Evonik is currently valued at just €9.2 billion.
"Evonik's comparatively low valuation makes it an attractive potential partner," said Linus Vogel of Deka Investment, a top-20 investor in both companies.
The business case and its limits
The product ranges are largely complementary. Evonik makes high-tech plastics, feed additives and ingredients for coatings and household products, while BASF makes engineering plastics, super absorbent polymers, vitamins and a wide range of industrial chemicals.
Arne Rautenberg, head of equities at Union Investment, said there was a sound business case: "By acquiring Evonik, BASF could strengthen its position in the speciality chemicals sector and increase capacity utilisation."
Geographically, however, the companies are less complementary — Europe is the largest market for both, while BASF has pledged to increase revenue contributions from Asia and other regions. Rising energy costs and weak demand have held back the whole European chemicals sector.
Stakes and what comes next
The context makes the timing pointed. According to Global Banking & Finance Review, BASF CEO Markus Kamieth said in June that the business environment was at its most difficult in at least the last 25 years, with the global balance of industrial power shifting to Asia.
BASF is at risk of losing its years-long rank as the world's largest company by chemicals revenue to China's Sinopec: last year BASF's group revenue of €59.7 billion ($68.9 billion) was almost the same as Sinopec's chemicals segment.
Kamieth has been seeking to make BASF more focused, exiting businesses not integrated with its chemical plants, while European producers have received a temporary boost from supply disruptions hitting Asian rivals harder.
A deal is far from certain, but the approach signals consolidation pressure on the continent.